<DOC>
	<DOCNO>NCT02822625</DOCNO>
	<brief_summary>QUTENZA® skin patch high concentration capsaicin ( 8 % ) component responsible spicy pepper . QUTENZA® indicate treatment peripheral neuropathic pain non-diabetic adult either alone combination analgesic . Acute pain experience procedure relieve local cool method oral analgesic pain remain intense . The hypothesis hypnosis via standardize hypnotic message would increase local tolerance treatment apply patch QUTENZA® . To date , study confirm refute hypothesis .</brief_summary>
	<brief_title>Efficacity Standardized Hypnotic Message During Application Qutenza ( Capsaicin ) 8 % Patch</brief_title>
	<detailed_description />
	<mesh_term>Capsaicin</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<criteria>Patient already receive least QUTENZA® patch Treatment patient failure conventional treatment neuropathic pain diabetic Age &gt; 18 year Eastern Cooperative Oncology Group ( ECOG ) performance status &lt; 3 Patient must affiliate social security system Ability provide write informed consent Patient 's legal capacity consent study participation understand comply requirement study Patient psychotic disorder Patient hear disorder Patient understand French language Age &lt; 18 year Patient require analgesic premedication apply patch QUTENZA® Patient history hypersensitivity capsaicin excipients patch Patient deprive liberty supervision</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Capsaicin</keyword>
	<keyword>QUTENZA®</keyword>
	<keyword>Hypnosis</keyword>
	<keyword>Peripheral Neuropathic</keyword>
</DOC>